Guyonnet-Duperat V - Search Results

1

Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method.

Laloo B, Simon D, Veillat V, Lauzel D, Guyonnet-Duperat V, Moreau-Gaudry F, Sagliocco F, Grosset C. Laloo B, et al. Mol Cell Proteomics. 2009 Aug;8(8):1777-88. doi: 10.1074/mcp.M800503-MCP200. Mol Cell Proteomics. 2009. PMID: 19411282 Free PMC article.

2

Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia.

Pocaly M, Lagarde V, Etienne G, Ribeil JA, Claverol S, Bonneu M, Moreau-Gaudry F, Guyonnet-Duperat V, Hermine O, Melo JV, Dupouy M, Turcq B, Mahon FX, Pasquet JM. Pocaly M, et al. Leukemia. 2007 Jan;21(1):93-101. doi: 10.1038/sj.leu.2404463. Epub 2006 Nov 16. Leukemia. 2007. PMID: 17109025

3

Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.

Robert-Richard E, Moreau-Gaudry F, Lalanne M, Lamrissi-Garcia I, Cario-André M, Guyonnet-Dupérat V, Taine L, Ged C, de Verneuil H. Robert-Richard E, et al. Am J Hum Genet. 2008 Jan;82(1):113-24. doi: 10.1016/j.ajhg.2007.09.007. Am J Hum Genet. 2008. PMID: 18179890 Free PMC article.

4

Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.

Robert-Richard E, Lalanne M, Lamrissi-Garcia I, Guyonnet-Duperat V, Richard E, Pitard V, Mazurier F, Moreau-Gaudry F, Ged C, de Verneuil H. Robert-Richard E, et al. J Gene Med. 2010 Aug;12(8):637-46. doi: 10.1002/jgm.1478. J Gene Med. 2010. PMID: 20586119

5

Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.

Bedel A, Taillepierre M, Guyonnet-Duperat V, Lippert E, Dubus P, Dabernat S, Mautuit T, Cardinaud B, Pain C, Rousseau B, Lalanne M, Ged C, Duchartre Y, Richard E, de Verneuil H, Moreau-Gaudry F. Bedel A, et al. Am J Hum Genet. 2012 Jul 13;91(1):109-21. doi: 10.1016/j.ajhg.2012.05.026. Am J Hum Genet. 2012. PMID: 22795135 Free PMC article.

6

In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens.

Lafitte M, Rousseau B, Moranvillier I, Taillepierre M, Peuchant E, Guyonnet-Dupérat V, Bedel A, Dubus P, de Verneuil H, Moreau-Gaudry F, Dabernat S. Lafitte M, et al. Mol Cancer. 2012 Oct 22;11:81. doi: 10.1186/1476-4598-11-81. Mol Cancer. 2012. PMID: 23088623 Free PMC article.

7

FGFR3 has tumor suppressor properties in cells with epithelial phenotype.

Lafitte M, Moranvillier I, Garcia S, Peuchant E, Iovanna J, Rousseau B, Dubus P, Guyonnet-Dupérat V, Belleannée G, Ramos J, Bedel A, de Verneuil H, Moreau-Gaudry F, Dabernat S. Lafitte M, et al. Mol Cancer. 2013 Jul 31;12:83. doi: 10.1186/1476-4598-12-83. Mol Cancer. 2013. PMID: 23902722 Free PMC article.

8

Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.

Bedel A, Beliveau F, Lamrissi-Garcia I, Rousseau B, Moranvillier I, Rucheton B, Guyonnet-Dupérat V, Cardinaud B, de Verneuil H, Moreau-Gaudry F, Dabernat S. Bedel A, et al. Stem Cells Transl Med. 2017 Feb;6(2):382-393. doi: 10.5966/sctm.2016-0201. Epub 2016 Sep 7. Stem Cells Transl Med. 2017. PMID: 28191782 Free PMC article.

9

HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53.

Capdevielle C, Desplat A, Charpentier J, Sagliocco F, Thiebaud P, Thézé N, Fédou S, Hooks KB, Silvestri R, Guyonnet-Duperat V, Petrel M, Raymond AA, Dupuy JW, Grosset CF, Hagedorn M. Capdevielle C, et al. Among authors: guyonnet duperat v. Neuro Oncol. 2020 Apr 15;22(4):550-562. doi: 10.1093/neuonc/noz215. Neuro Oncol. 2020. PMID: 31711240 Free PMC article.

10

CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer.

Boutin J, Genevois C, Couillaud F, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, Lalanne M, Amintas S, Moranvillier I, Richard E, Blouin JM, Dabernat S, Moreau-Gaudry F, Bedel A. Boutin J, et al. Among authors: guyonnet duperat v. Mol Ther Oncol. 2024 Feb 8;32(1):200772. doi: 10.1016/j.omton.2024.200772. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page